Key facts
- This page summarizes Daniel S. Jonas's Form 4 filing for CONMED Corp (CNMD).
- 6 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 May 2023, 16:19.
Daniel S. Jonas - 28 Apr 2023 Form 4 Insider Report for CONMED Corp (CNMD)
- Reporting relationship
- Special Counsel & Corp Secy
- Issuer ticker
- CNMD
- Reported as of
- 28 Apr 2023
- Net transaction value
- -$284,143
- SEC form
- 4
- Accepted by SEC
- 02 May 2023, 16:19:48 UTC
- Prior SEC filing
- 04 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- Daniel S. Jonas
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel S. Jonas filed Form 4 for CONMED Corp (CNMD) on 02 May 2023.
Change
- Previous filing in this sequence was filed on 04 Apr 2023.
- Current net transaction value: -$284,143.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CNMD
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -626
- Change %
- -4.4%
- Price
- $0.000000
- Shares after
- 13,462
- Date
- 28 Apr 2023
- Ownership
- Direct
CNMD
transaction
Common Stock
Options Exercise
- Transaction value
- $976,900
- Shares
- +10,000
- Change %
- +74%
- Price
- $97.69
- Shares after
- 23,462
- Date
- 28 Apr 2023
- Ownership
- Direct
CNMD
transaction
Common Stock
Sale
- Transaction value
- $690,635
- Shares
- -5,500
- Change %
- -23%
- Price
- $125.57
- Shares after
- 17,962
- Date
- 28 Apr 2023
- Ownership
- Direct
- Footnotes
- F1
CNMD
transaction
Common Stock
Sale
- Transaction value
- $544,896
- Shares
- -4,300
- Change %
- -24%
- Price
- $126.72
- Shares after
- 13,662
- Date
- 28 Apr 2023
- Ownership
- Direct
- Footnotes
- F2
CNMD
transaction
Common Stock
Sale
- Transaction value
- $25,512
- Shares
- -200
- Change %
- -1.5%
- Price
- $127.56
- Shares after
- 13,462
- Date
- 28 Apr 2023
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CNMD
transaction
Derivative
Options To Purchase Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 10,000
- Date
- 28 Apr 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $97.69
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.30 to $126.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.36 to $127.26. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder,
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.42 to $127.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
Footnote F4
The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period